These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4237624)

  • 21. Studies on an inhibitor of plasminogen activators in human platelets.
    Murray J; Crawford GP; Ogston D; Douglas AS
    Br J Haematol; 1974 Apr; 26(4):661-8. PubMed ID: 4276857
    [No Abstract]   [Full Text] [Related]  

  • 22. [Haptoglobin in hepatic cirrhosis].
    Gillardi U; Daniele F; Rizzi D
    Boll Soc Ital Biol Sper; 1964 Nov; 40(21):1341-3. PubMed ID: 5877072
    [No Abstract]   [Full Text] [Related]  

  • 23. [Decomposition products of fibrin(ogen) and collateral circulation in liver cirrhosis].
    Bungert HJ; Leonhardt H
    Z Gastroenterol; 1973 Apr; 11(3):187-94. PubMed ID: 4803419
    [No Abstract]   [Full Text] [Related]  

  • 24. Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits.
    Levi M; Friederich PW; Middleton S; de Groot PG; Wu YP; Harris R; Biemond BJ; Heijnen HF; Levin J; ten Cate JW
    Nat Med; 1999 Jan; 5(1):107-11. PubMed ID: 9883848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of long-term, low-dose tranexamic acid treatment on platelet dysfunction and haemoglobin levels in haemodialysis patients.
    Sabovic M; Zupan IP; Salobir B; Zupan I; Cernelc P; Lavre J; Vujkovac B
    Thromb Haemost; 2005 Dec; 94(6):1245-50. PubMed ID: 16411401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombin generation in patients with cirrhosis: the role of platelets.
    Tripodi A; Primignani M; Chantarangkul V; Clerici M; Dell'Era A; Fabris F; Salerno F; Mannucci PM
    Hepatology; 2006 Aug; 44(2):440-5. PubMed ID: 16871542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of antiplasmin on fibrinolysis and fibrinogenolysis].
    Bratus' GM; Byshevskiĭ ASh
    Ukr Biokhim Zh; 1971; 43(2):178-82. PubMed ID: 4254692
    [No Abstract]   [Full Text] [Related]  

  • 28. A guide for diagnosis of patients with arterial and venous thrombosis.
    Quinn C; Hill J; Hassouna H
    Clin Lab Sci; 2000; 13(4):229-38. PubMed ID: 11586510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitors of fibrinolysis: evidence of some instances of mutual potentiation.
    Coccheri S; De Rosa V
    J Clin Pathol; 1972 Jul; 25(7):627-8. PubMed ID: 4262716
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in fibrinogen level in liver cirrhosis.
    Arif S; Khan AS; Khan AR
    J Ayub Med Coll Abbottabad; 2002; 14(2):19-21. PubMed ID: 12238339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Considerations on the fibrinolytic enzymatic system and maternal serum and umbilical-cord fibrinogen in normal and gestosic pregnancy].
    Tanferna M; Giordano G; Giannice C
    Arch Sci Med (Torino); 1968 Nov; 125(11):629-35. PubMed ID: 4239824
    [No Abstract]   [Full Text] [Related]  

  • 32. [Behavior of human plasmin inhibitors in intravascularly increased fibrinolytic activity].
    Fischer M
    Thromb Diath Haemorrh; 1970 Jun; 23(3):513-52. PubMed ID: 4247030
    [No Abstract]   [Full Text] [Related]  

  • 33. Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit.
    Hu KQ; Yu AS; Tiyyagura L; Redeker AG; Reynolds TB
    Am J Gastroenterol; 2001 May; 96(5):1581-6. PubMed ID: 11374703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Görög Thrombosis Test: a global in-vitro test of platelet function and thrombolysis.
    Yamamoto J; Yamashita T; Ikarugi H; Taka T; Hashimoto M; Ishii H; Watanabe S; Kovacs IB
    Blood Coagul Fibrinolysis; 2003 Jan; 14(1):31-9. PubMed ID: 12544726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evaluation of plasmin and streptokinase activator complexes in a new rabbit model of venous thrombosis.
    Dupe RJ; English PD; Smith RA; Green J
    Thromb Haemost; 1981 Aug; 46(2):528-34. PubMed ID: 6458112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative and qualitative analysis of platelet GPIb and von Willebrand factor in liver cirrhosis.
    Beer JH; Clerici N; Baillod P; von Felten A; Schlappritzi E; Büchi L
    Thromb Haemost; 1995 Apr; 73(4):601-9. PubMed ID: 7495066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coagulation factors as indicators of protein synthesis in chronic liver disease.
    Ritland S; Skrede S; Blomhoff JP; Gjone E
    Scand J Gastroenterol Suppl; 1973; 19():113-7. PubMed ID: 4515633
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification of human platelet membrane fibrinogen receptors by immunochemical techniques.
    Kornecki E; Tuszynski GP; Niewiarowski S
    Haematologia (Budap); 1984; 17(3):387-98. PubMed ID: 6100105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fibrinolysis in chronic liver diseases studied by in vitro blood coagulation tests].
    Pósán E; Tornai I; Udvardy M
    Orv Hetil; 1994 Dec; 135(51):2821-4. PubMed ID: 7838517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.